• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植中的细胞外囊泡:最新综述。

Extracellular vesicles in kidney transplantation: a state-of-the-art review.

机构信息

Department of Surgery, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK.

Department of Surgery, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK; Blood and Transplant Research Unit in Organ Donation and Transplantation, National Institute for Health Research, University of Cambridge, Cambridge, UK.

出版信息

Kidney Int. 2022 Mar;101(3):485-497. doi: 10.1016/j.kint.2021.10.038. Epub 2021 Nov 26.

DOI:10.1016/j.kint.2021.10.038
PMID:34838864
Abstract

Kidney transplantation is the optimal treatment for patients with kidney failure; however, early detection and timely treatment of graft injury remain a challenge. Precise and noninvasive techniques of graft assessment and innovative therapeutics are required to improve kidney transplantation outcomes. Extracellular vesicles (EVs) are lipid bilayer-delimited particles with unique biosignatures and immunomodulatory potential, functioning as intermediaries of cell signalling. Promising evidence exists for the potential of EVs to develop precision diagnostics of graft dysfunction, and prognostic biomarkers for clinician decision making. The inherent targeting characteristics of EVs and their low immunogenic and toxicity profiles combined with their potential as vehicles for drug delivery make them ideal targets for development of therapeutics to improve kidney transplant outcomes. In this review, we summarize the current evidence for EVs in kidney transplantation, discuss common methodological principles of EV isolation and characterization, explore upcoming innovative approaches in EV research, and discuss challenges and opportunities to enable translation of research findings into clinical practice.

摘要

肾移植是肾衰竭患者的最佳治疗方法;然而,早期发现和及时治疗移植物损伤仍然是一个挑战。需要精确和非侵入性的移植物评估技术和创新的治疗方法来改善肾移植的结果。细胞外囊泡(EVs)是具有独特生物特征和免疫调节潜力的脂质双层限定颗粒,作为细胞信号转导的中介。有令人鼓舞的证据表明,EVs 有可能开发出用于检测移植物功能障碍的精准诊断方法,以及用于临床医生决策的预后生物标志物。EVs 的固有靶向特性及其低免疫原性和低毒性特征,加上它们作为药物递送载体的潜力,使它们成为改善肾移植结果的治疗药物开发的理想目标。在这篇综述中,我们总结了 EVs 在肾移植中的现有证据,讨论了 EV 分离和表征的常见方法学原则,探讨了 EV 研究中的新方法,并讨论了将研究结果转化为临床实践的挑战和机遇。

相似文献

1
Extracellular vesicles in kidney transplantation: a state-of-the-art review.肾移植中的细胞外囊泡:最新综述。
Kidney Int. 2022 Mar;101(3):485-497. doi: 10.1016/j.kint.2021.10.038. Epub 2021 Nov 26.
2
Update on current and potential application of extracellular vesicles in kidney transplantation.细胞外囊泡在肾移植中当前和潜在应用的最新进展。
Am J Transplant. 2023 Nov;23(11):1673-1693. doi: 10.1016/j.ajt.2023.07.010. Epub 2023 Jul 28.
3
Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction.早期和晚期肾移植功能障碍生物标志物的最新进展。
Int J Mol Sci. 2020 Jul 29;21(15):5404. doi: 10.3390/ijms21155404.
4
Extracellular vesicles for renal therapeutics: State of the art and future perspective.细胞外囊泡在肾脏治疗中的应用:现状与未来展望。
J Control Release. 2022 Sep;349:32-50. doi: 10.1016/j.jconrel.2022.06.049. Epub 2022 Jul 4.
5
Extracellular vesicles for drug delivery.细胞外囊泡用于药物递送。
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):148-156. doi: 10.1016/j.addr.2016.02.006. Epub 2016 Feb 27.
6
Engineered Extracellular Vesicles in Chronic Kidney Diseases: A Comprehensive Review.慢性肾脏病中的工程化细胞外囊泡:综述
Int J Nanomedicine. 2024 Mar 7;19:2377-2393. doi: 10.2147/IJN.S452393. eCollection 2024.
7
Therapeutic efficacy of extracellular vesicles to suppress allograft rejection in preclinical kidney transplantation models: A systematic review and meta-analysis.外泌体抑制临床前肾移植模型中同种异体移植排斥反应的疗效:系统评价和荟萃分析。
Transplant Rev (Orlando). 2022 Dec;36(4):100714. doi: 10.1016/j.trre.2022.100714. Epub 2022 Jul 13.
8
Extracellular Vesicles as Drug Delivery Systems in Organ Transplantation: The Next Frontier.细胞外囊泡作为器官移植中的药物递送系统:下一个前沿领域。
Pharmaceutics. 2023 Mar 9;15(3):891. doi: 10.3390/pharmaceutics15030891.
9
The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.细胞外囊泡作为治疗载体的挑战和可能性。
Eur J Pharm Biopharm. 2019 Nov;144:50-56. doi: 10.1016/j.ejpb.2019.08.009. Epub 2019 Aug 13.
10
Extracellular Vesicles as Mediators of Cellular Crosstalk Between Immune System and Kidney Graft.细胞外囊泡作为免疫系统和肾脏移植物之间细胞串扰的介质。
Front Immunol. 2020 Feb 27;11:74. doi: 10.3389/fimmu.2020.00074. eCollection 2020.

引用本文的文献

1
CD133+CD24+ Renal Tubular Progenitor Cells Drive Hypoxic Injury Recovery via Hypoxia-Inducible Factor-1A and Epidermal Growth Factor Receptor Expression.CD133+CD24+肾小管祖细胞通过缺氧诱导因子-1A和表皮生长因子受体表达驱动缺氧损伤恢复。
Int J Mol Sci. 2025 Mar 10;26(6):2472. doi: 10.3390/ijms26062472.
2
Recent Insights in Noninvasive Diagnostic for the Assessment of Kidney and Cardiovascular Outcome in Kidney Transplant Recipients.肾移植受者肾脏和心血管结局评估的非侵入性诊断新见解
J Clin Med. 2024 Jun 27;13(13):3778. doi: 10.3390/jcm13133778.
3
Podocyte-specific proteins in urinary extracellular vesicles of patients with IgA nephropathy: Vasorin and ceruloplasmin.
IgA肾病患者尿细胞外囊泡中的足细胞特异性蛋白:血管紧张素原和铜蓝蛋白。
Bioimpacts. 2024;14(3):29981. doi: 10.34172/bi.2023.29981. Epub 2023 Oct 31.
4
Molecular immune monitoring in kidney transplant rejection: a state-of-the-art review.肾移植排斥反应的分子免疫监测:最新综述。
Front Immunol. 2023 Aug 22;14:1206929. doi: 10.3389/fimmu.2023.1206929. eCollection 2023.
5
Physiopathological role of extracellular vesicles in alloimmunity and kidney transplantation and their use as biomarkers.细胞外囊泡在同种异体免疫和肾移植中的病理生理学作用及其作为生物标志物的应用。
Front Immunol. 2023 Aug 17;14:1154650. doi: 10.3389/fimmu.2023.1154650. eCollection 2023.
6
Human Adult Renal Progenitor Cells Prevent Cisplatin-Nephrotoxicity by Inducing CYP1B1 Overexpression and miR-27b-3p Down-Regulation through Extracellular Vesicles.人成肾祖细胞通过细胞外囊泡诱导 CYP1B1 过表达和 miR-27b-3p 下调,预防顺铂肾毒性。
Cells. 2023 Jun 17;12(12):1655. doi: 10.3390/cells12121655.
7
Current Evidence and Future Perspectives to Implement Continuous and End-Ischemic Use of Normothermic and Oxygenated Hypothermic Machine Perfusion in Clinical Practice.在临床实践中实施常温及氧合低温机器灌注持续和缺血末期使用的当前证据及未来展望。
J Clin Med. 2023 Apr 29;12(9):3207. doi: 10.3390/jcm12093207.
8
Extracellular Vesicles: The Future of Diagnosis in Solid Organ Transplantation?细胞外囊泡:实体器官移植诊断的未来?
Int J Mol Sci. 2023 Mar 7;24(6):5102. doi: 10.3390/ijms24065102.
9
Rejection markers in kidney transplantation: do new technologies help children?肾移植中的排斥标志物:新技术是否对儿童有帮助?
Pediatr Nephrol. 2023 Sep;38(9):2939-2955. doi: 10.1007/s00467-022-05872-z. Epub 2023 Jan 17.
10
Direct detection of circulating donor-derived extracellular vesicles in kidney transplant recipients.直接检测肾移植受者循环供体来源的细胞外囊泡。
Sci Rep. 2022 Dec 20;12(1):21973. doi: 10.1038/s41598-022-26580-6.